Tool Calling and Plugins for siRNA Nucleic Acid Drug Pharmacovigilance

siRNA nucleic acid drug pharmacovigilance data primarily originates from clinical trial reports, real-world studies, adverse event reporting systems

Data Characteristics for this Category

siRNA nucleic acid drug pharmacovigilance data primarily originates from clinical trial reports, real-world studies, adverse event reporting systems (e.g., FDA FAERS, EMA EudraVigilance), and relevant literature. Data update frequencies vary. Clinical trial data typically releases in bulk after the trial period. Real-world data and adverse event reports accumulate continuously. Data document structures are diverse. They include structured database records, semi-structured XML or JSON files, and unstructured clinical report PDFs or free-text descriptions. Beyond common fields like general drug information, patient demographics, adverse event descriptions (MedDRA codes), medication history, and concomitant medications, siRNA nucleic acid drugs include specific fields such as target information, nucleic acid sequence variations, and delivery system types. Doses are often in mg/kg or mg. Adverse event incidence rates are in percentage or number of cases / total exposed individuals.

Constraints Imposed by These Characteristics on "Tool Calling and Plugins"

The diverse sources and unstructured nature of siRNA nucleic acid drug data present integration and parsing challenges for tool calling. Data from systems like FAERS are often bulk CSV or XML downloads, requiring plugins with file parsing capabilities. Unstructured clinical reports contain adverse event information that demands Natural Language Processing (NLP) for key entity and relationship extraction. Inconsistent update frequencies mean tool calls need to support scheduled tasks and incremental update strategies to avoid duplicate processing and data omissions. siRNA-specific fields, such as nucleic acid sequences and target information, require customized data models and query logic for drug interaction or adverse event association analysis. Generic plugins may not directly support these. Accurate identification and mapping of specialized terminology like MedDRA codes are crucial for consistent adverse event classification.

Configuration Settings

Configuration ItemRecommended ValueRationale
API_TIMEOUT_SECONDS120 secondsExtends timeout for large report parsing and complex queries, preventing interruptions.
MAX_FILE_SIZE_MB200 MBSupports common clinical study report PDF file sizes.
PARSE_CONCURRENT_LIMIT5Balances system resource usage with processing efficiency, allowing parallel file parsing.
MedDRA_VERSION26.0Ensures adverse event coding aligns with the latest international standards, improving data interoperability.
CHUNK_SIZE_TOKENS1000–1500 tokensOptimizes NLP model context window utilization for long text while maintaining processing efficiency.
REPORT_RETRIEVAL_INTERVALOnce daily or Once weeklySets appropriate report retrieval frequency based on database update rates (e.g., FAERS) to ensure data timeliness.

Three Common Mistakes

  • External API calls return an HTTP 400 Bad Request error. This occurs because the request body lacks siRNA nucleic acid drug-specific fields like sequence_id or delivery_system.
  • After parsing a large clinical report PDF, key adverse event description fields are empty. This happens because the plugin is not configured to extract content from tables or specific sections within the report.
  • Tool call logs show Execution Timeout. This typically occurs when attempting to process large amounts of historical data or perform complex association queries, due to a low API_TIMEOUT_SECONDS setting.

How to Verify Configuration

  • Upload a test report containing siRNA nucleic acid sequence information and adverse event descriptions. Check if the sequence_id and MedDRA_Preferred_Term fields are correctly populated in the parsing results.
  • Use the plugin to call an external drug interaction database. Input a known siRNA nucleic acid drug and common drug combination. Verify if the returned interaction risk alerts match expectations.
  • Simulate a large-volume query, such as retrieving all adverse events for a specific target siRNA nucleic acid drug over the past year. Observe if the tool call response time is within an acceptable range.

The values provided are common starting points and should be measured against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.